Thomson Reuters

Newport Horizon SourcingTM is an expert competitive intelligence system for generic pharmaceutical companies and strategic API (Active Pharmaceutical Ingredient) manufacturers.

Powered by unique early intelligence and analysis available only from Thomson, the
industry authority on global API development activities, Newport Horizon Sourcing contains detailed profiles of close to 10,000 active ingredients, 12,000 corporate groups and 3,000 API production sites worldwide.

Expert competitive intelligence on the global generic market.

With Newport Horizon Sourcing, you can:

• Identify early, exclusive or alternative sources of API supply ahead of the competition.
• Leverage unique competitive intelligence on suppliers and developers of API worldwide during sourcing negotiations.
• Determine potential suppliers based on specific technical and manufacturing capabilities.
• Monitor patenting activities of API manufacturers worldwide.
• Investigate products and analyze patent, exclusivity and regulatory information.
  

Why choose Newport Horizon Sourcing?

• Unique early API development intelligence and competitive forecasts.
• Coverage of close to 10,000 active pharmaceutical ingredients.
• Worldwide patent families and patents by country filed by innovators, API manufacturers, and generic companies together with US and European exclusivities.
• US Drug Master File, Orange Book and European Certificate of Suitability data.
• Chemical structures and potential routes of synthesis.
• Profiles of 12,000 corporate groups and 3,000 API facilities including detailed manufacturing capabilities for an increasing number of producers.
  

• Monthly data updates.
• Intuitive, easy-to-use web technology.
• Comprehensive training and technical support.
• Flexible licensing options.
• Zero cost deployment.
• Secure, confidential access.